Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer.
- DOI
- 10.1016/j.neo.2014.05.010
- Published
- 2014 Jun
- Container
- Neoplasia (New York, N.Y.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.neo.2014.05.010,
title = {Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer.},
author = {Knoop RF and Sparn M and Waldmann J and Plassmeier L and Bartsch DK and Lauth M and Hudemann C and Fendrich V},
year = {2014},
journal = {Neoplasia (New York, N.Y.)},
doi = {10.1016/j.neo.2014.05.010},
url = {https://doi.org/10.1016/j.neo.2014.05.010}
}RIS
TY - JOUR TI - Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer. AU - Knoop RF AU - Sparn M AU - Waldmann J AU - Plassmeier L AU - Bartsch DK AU - Lauth M AU - Hudemann C AU - Fendrich V PY - 2014 JO - Neoplasia (New York, N.Y.) DO - 10.1016/j.neo.2014.05.010 UR - https://doi.org/10.1016/j.neo.2014.05.010 ER -
APA
RF, K., M, S., J, W., L, P., DK, B., M, L., C, H., & V, F. (2014). Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer.. Neoplasia (New York, N.Y.). https://doi.org/10.1016/j.neo.2014.05.010
Source records
- pubmed · retrieved 2026-09-26T22:55:53.598Z